Plain-English translation of NCT06899854 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is collecting blood and tissue samples from people with primary liver cancer—either hepatocellular carcinoma or cholangiocarcinoma—who are receiving treatment, having surgery, or undergoing a biopsy. The samples will be used to help researchers better understand these cancers and develop new, more effective therapies. Your participation could directly contribute to improving treatment options for patients with liver cancer.
Liver cancer is becoming more common worldwide, and current treatments are not effective enough for many patients. Researchers need biological samples from patients undergoing actual treatment to study the disease more deeply and create new therapeutic approaches that could save lives.
You likely qualify if…
You likely don't qualify if…
If you receive systemic therapy (medication), you'll have blood drawn at the start of treatment, during your first three follow-up visits, at the end of treatment, and after your first imaging scan. If you're having surgery, researchers will collect blood and a small tissue sample that isn't needed for diagnosing your cancer. If you're having a biopsy, you'll provide a blood sample and researchers will collect extra biopsy tissue. The study runs for three years, and your samples will be processed and stored for future research.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
Italy